| |
| |
|
| Insider
Information: |
Hausman Diane |
| Relationship: |
Chief Medical Officer |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
379,253 |
|
|
Indirect Shares
|
7,747 |
|
|
| Direct
Value |
$47,371 |
|
|
|
Indirect Value
|
$17,620 |
|
|
| Total
Shares |
387,000 |
|
|
| Total
Value |
$64,991 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cascadian Therapeutics, Inc |
CASC |
Chief Medical Officer |
2015-06-01 |
0 |
2015-06-01 |
5,747 |
Premium* |
|
|
Zymeworks Inc |
ZYME |
Chief Medical Officer |
2021-03-10 |
5,377 |
2021-03-10 |
2,000 |
Premium* |
|
|
Zentalis Pharmaceuticals, Llc |
ZNTL |
Chief Medical Officer |
2024-05-09 |
373,876 |
2023-05-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Medical Officer |
• – – |
2024-05-09 |
4 |
S |
$12.62 |
$42,353 |
D/D |
(3,356) |
373,876 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Medical Officer |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
337,500 |
377,232 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2023-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
39,732 |
39,732 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2021-03-10 |
4 |
AS |
$34.95 |
$36,631 |
D/D |
(1,048) |
5,377 |
0 |
% |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
6,425 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2021-01-07 |
4 |
A |
$30.92 |
$6,400 |
D/D |
207 |
3,925 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-12-04 |
4 |
AS |
$55.12 |
$332,476 |
D/D |
(6,032) |
3,718 |
0 |
% |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-12-04 |
4 |
OE |
$9.82 |
$65,662 |
D/D |
6,032 |
9,750 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-12-02 |
4 |
AS |
$55.01 |
$38,563 |
D/D |
(701) |
3,718 |
0 |
% |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-12-02 |
4 |
OE |
$9.82 |
$8,043 |
D/D |
701 |
4,419 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-12-01 |
4 |
AS |
$55.19 |
$1,008,240 |
D/D |
(18,267) |
3,718 |
0 |
% |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-12-01 |
4 |
OE |
$9.82 |
$207,955 |
D/D |
18,267 |
21,985 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-09-14 |
4 |
AS |
$45.00 |
$1,800,000 |
D/D |
(40,000) |
3,718 |
0 |
% |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-09-14 |
4 |
OE |
$9.82 |
$545,500 |
D/D |
40,000 |
43,718 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-07-02 |
4 |
A |
$30.66 |
$11,252 |
D/D |
367 |
3,718 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2020-01-08 |
4 |
A |
$19.54 |
$6,487 |
D/D |
332 |
3,351 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
A |
$12.49 |
$6,495 |
D/D |
520 |
3,019 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Chief Medical Officer |
• – – |
2019-01-08 |
4 |
A |
$12.48 |
$6,228 |
D/D |
499 |
2,499 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Chief Medical Officer |
• – – |
2015-06-01 |
4 |
B |
$4.65 |
$26,724 |
I/I |
5,747 |
5,747 |
1.99 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
